Timothy Kamaldinov
FDA investigator
Appears on 3 documents from 2024 to 2025, most often at sites in Massachusetts. Most often cites production record review (21 CFR 211.192).
- 3
- Documents on file
- 6.0
- Observations per 483
- 2024
- First seen
- 2025
- Most recent
What they cite most
From 18 observations- 21 CFR 211.192Production record review3
- 21 CFR 211.113Control of microbiological contamination2
- 21 CFR 211.100Written procedures; deviations1
- 21 CFR 211.180General requirements1
- 21 CFR 211.22Responsibilities of quality control unit1
- 21 CFR 211.42Design and construction features1
Activity by year
2024: 1, 2025: 2
Where
Massachusetts 1 · New Hampshire 1
Often inspects with
Is Timothy Kamaldinov coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
3 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2025-06-06 | 483 Lonza Portsmouth, Inc.Jun 6, 2025 · Portsmouth, New Hampshire | Portsmouth, New Hampshire | 10 | |
| 2025-04-25 | 483 FDA Form 483 Ultragenyx Pharmaceutical Inc, Bedford, MA April 2025Apr 25, 2025 · Bedford, Massachusetts | Bedford, Massachusetts | 6 | |
| 2024-07-12 | 483 FDA Form 483 Lonza Netherlands BV, Geleen, Netherlands, July 2024Jul 12, 2024 | — | 2 |
About this profile
What does Timothy Kamaldinov inspect?
Timothy Kamaldinov appears on 3 documents on file covering 3 sites, most often in Massachusetts.
What do they cite most often?
21 CFR 211.192 (production record review), followed by 21 CFR 211.113 and 21 CFR 211.100.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Timothy Kamaldinov is dated Jun 6, 2025.